Diadema Partners LP Pro Qr Therapeutics N.V. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Diadema Partners LP holds 207,694 shares of PRQR stock, worth $369,695. This represents 0.07% of its overall portfolio holdings.
Number of Shares
207,694
Previous 158,023
31.43%
Holding current value
$369,695
Previous $419 Million
34.04%
% of portfolio
0.07%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
69Shares Held
42.1MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$14.4 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.87 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.85 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.69 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.66 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $127M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...